Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists find potential toxoplasmosis drug target
Toxoplasmosis can be transmitted through soil, undercooked meat or from contact with cat faeces.
Study reveals enzyme that is crucial for the parasite’s survival

Researchers at the University of Glasgow have found a potential weakness in the Toxoplasma parasite that may eventually lead to a new drug target.

Writing in Plos Pathogens, scientists describe how they have found a key enzyme in the toxoplasmosis-causing parasite (thioredoxin) which is essential for its survival. The team are now working with industry partners to create new drugs that would target this enzyme and kill the parasite.

“More and more studies highlight the parasite’s sensitivity to redox imbalance – a key function of the enzyme we have studied,” said Dr Sheiner, from the University’s Wellcome Centre for Molecular Parasitology.

“Targeting the thioredoxin enzyme may make them vulnerable at stages of their life that are important for infection and dissemination. Finding enzymes in the parasite that we can target, and that don’t influence the human host, unravels this potentially deadly parasite’s Achilles’ heel.”

Toxoplasmosis is a common infection that is caused by the Toxoplasma parasite. It can be transmitted through soil, undercooked meat or from contact with cat faeces.

While most people who become infected with toxoplasmosis are not aware of it, the disease can be dangerous to unborn children and people with compromised immune systems.

Because the toxoplasmosis parasite is also used to learn about the biology of malaria-causing parasites, the team hope that their work will also lead to new drug targets for malaria.

Dr Sheiner said: “Our original interest in this research was not in drug discovery, rather we are excited to learn about how parasites work and how evolution provided them with special tools to serve their parasitic lifestyle. But, as in this case, we are obviously very happy if we stumble across promising targets for new drugs.”

Michael Chew, from Wellcome’s Infection and Immunobiology team, added: “Around a third of the UK population are thought to carry the Toxoplasma parasite. Normally a dormant parasite, it can lead to serious neurological harm when “awakened” in people with compromised immunity, like HIV patients, or those with an immature immune system, like infants and unborn children.

“This research is a great example of how basic, discovery science can lead to new drug targets for dangerous diseases.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.